Compare MGPI & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGPI | IVVD |
|---|---|---|
| Founded | 1941 | 2020 |
| Country | United States | United States |
| Employees | 267 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.0M | 437.1M |
| IPO Year | 1994 | 2021 |
| Metric | MGPI | IVVD |
|---|---|---|
| Price | $18.27 | $1.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $30.00 | $8.75 |
| AVG Volume (30 Days) | 329.4K | ★ 1.8M |
| Earning Date | 05-27-2026 | 06-08-2026 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | ★ 79.02 |
| EPS | N/A | ★ N/A |
| Revenue | $19,782,000.00 | ★ $53,426,000.00 |
| Revenue This Year | N/A | $143.48 |
| Revenue Next Year | $5.11 | $25.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 110.47 |
| 52 Week Low | $18.10 | $0.46 |
| 52 Week High | $34.50 | $3.07 |
| Indicator | MGPI | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 21.80 | 57.32 |
| Support Level | N/A | $1.41 |
| Resistance Level | $25.99 | $2.01 |
| Average True Range (ATR) | 0.93 | 0.11 |
| MACD | -0.56 | 0.05 |
| Stochastic Oscillator | 6.46 | 96.00 |
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.